SmartTRAK was once again cited as a trusted source for market data, this time in the Orthofix Q219 Earnings Call and press release.
On the Earnings Call, Mr Mason said "Also, we are pleased to report that based on recent SmartTRAK data, we believe that we have now achieved the number one position in the cellular allograft market, with over $100 million of sales to hospitals in the last 12 months. Based on our first half performance, we now expect our full year sales growth expectations to be in the high single digits for this business."
SmartTRAK was also cited as a source in a recent Smith & Nephew press release regarding their meniscal knee repair technology.
SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click the button below.
Request a Demo of the SmartTRAK
Business Intelligence Portal!
